- Home
- DBD vs QDEL Comparison
DBD vs QDEL Comparison
Compare DBD & QDEL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | DBD | QDEL |
|---|---|---|
| Founded | 1859 | 1979 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | EDP Services | Medical Specialities |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.5B | 2.0B |
| IPO Year | 2023 | 2022 |
Fundamental Metrics
Financial Performance| Metric | DBD | QDEL |
|---|---|---|
| Price | $81.24 | $22.48 |
| Analyst Decision | Strong Buy | Hold |
| Analyst Count | 3 | 4 |
| Target Price | ★ $90.00 | $32.75 |
| AVG Volume (30 Days) | 295.3K | ★ 1.2M |
| Earning Date | 05-14-2026 | 05-06-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 677.27 | 45.35 |
| EPS | ★ 2.54 | N/A |
| Revenue | ★ $3,805,700,000.00 | $2,730,200,000.00 |
| Revenue This Year | $3.56 | $3.62 |
| Revenue Next Year | $3.25 | $4.07 |
| P/E Ratio | $31.89 | ★ N/A |
| Revenue Growth | ★ 1.46 | N/A |
| 52 Week Low | $34.88 | $19.50 |
| 52 Week High | $84.42 | $42.21 |
Technical Indicators
Market Signals| Indicator | DBD | QDEL |
|---|---|---|
| Relative Strength Index (RSI) | 71.97 | 31.63 |
| Support Level | $79.48 | $22.70 |
| Resistance Level | $84.42 | $24.75 |
| Average True Range (ATR) | 3.03 | 1.76 |
| MACD | 1.04 | -0.54 |
| Stochastic Oscillator | 79.84 | 14.92 |
Price Performance
Historical ComparisonAbout DBD Diebold Nixdorf Incorporated
Diebold Nixdorf Inc is engaged in providing software and hardware services for financial and retail industries. The customer segments of the company are Banking, which offers integrated solutions for financial institutions, and Retail, which offers solutions, software, and services that improve the checkout process for retailers. A majority of its revenue is generated from the Banking segment. Geographically, the company generates maximum revenue from Europe, Middle East, and Africa (EMEA), followed by the Americas and the Asia-Pacific region.
About QDEL QuidelOrtho Corporation
QuidelOrtho Corp is engaged in the development, manufacturing and marketing of rapid diagnostic testing solutions. The company is engaged in immunoassay and molecular testing, clinical chemistry and transfusion medicine which helps clinicians and patients to make decisions across the globe. Geographically the company has its presence in North America, EMEA, China and Other countries. It generates majority if its revenue from North America.